Glu Cell (GLUU) seems a pretty decide given a noticeable enchancment within the firm's earnings out
Glu Cell (GLUU) seems a pretty decide given a noticeable enchancment within the firm’s earnings outlook. The inventory has been a robust performer currently, and the momentum would possibly proceed with analysts nonetheless elevating their earnings estimates for the corporate.
The upward pattern in estimate revisions for this cell recreation maker displays rising optimism of analysts on its earnings prospects, which ought to get mirrored in its inventory worth. In spite of everything, empirical analysis exhibits a robust correlation between developments in earnings estimate revisions and near-term inventory worth actions. Our inventory score device — the Zacks Rank — is principally constructed on this perception.
The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Sturdy Purchase) to a Zacks Rank #5 (Sturdy Promote), has a powerful externally-audited monitor document of outperformance, with Zacks #1 Ranked shares producing a mean annual return of +25% since 2008.
For Glu Cell, sturdy settlement among the many masking analysts in revising earnings estimates upward has resulted in significant enchancment in consensus estimates for the subsequent quarter and full 12 months.
Present-Quarter Estimate Revisions
For the present quarter, the corporate is anticipated to earn $0.12 per share, which is a change of +20% from the year-ago reported quantity.
Over the past 30 days, the Zacks Consensus Estimate for Glu Cell has elevated 6.01% as a result of 5 estimates have moved larger whereas two have gone decrease.
Present-Yr Estimate Revisions
For the total 12 months, the earnings estimate of $0.41 per share represents a change of +141.18% from the year-ago quantity.
The revisions pattern for the present 12 months additionally seems fairly promising for Glu Cell, with seven estimates shifting larger over the previous month in comparison with one unfavourable revision. The consensus estimate has additionally acquired a lift over this time-frame, rising 36.36%.
Favorable Zacks Rank
The promising estimate revisions have helped Glu Cell earn a Zacks Rank #2 (Purchase). The Zacks Rank is a tried-and-tested score device that helps traders successfully harness the ability of earnings estimate revisions and make the best funding choice. You’ll be able to see the entire checklist of at the moment’s Zacks #1 Rank (Sturdy Purchase) shares right here.
Our analysis exhibits that shares with Zacks Rank #1 (Sturdy Purchase) and a pair of (Purchase) considerably outperform the S&P 500.
Backside Line
Whereas sturdy estimate revisions for Glu Cell have attracted respectable investments and pushed the inventory 6.3% larger over the previous 4 weeks, additional upside should still be left within the inventory. So, you might think about including it to your portfolio instantly.
Need the newest suggestions from Zacks Funding Analysis? As we speak, you’ll be able to obtain 7 Greatest Shares for the Subsequent 30 Days. Click on to get this free report
Glu Cell Inc. (GLUU): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.